|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Preeclampsia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Pre-Eclampsia | |||||
| 3 | More general conditions related to this trial | ||||
| Hypertension, Pregnancy-Induced | |||||
| Pregnancy Complications | |||||
| 4 | Interventions listed in this trial | ||||
| Vitamins C and E | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Alpha-Tocopherol | |||||
| Tocopherol acetate | |||||
| Tocopherols | |||||
| Vitamin E | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antioxidants | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Vitamins | |||||
| 7 | Sponsors listed in this trial | ||||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||